It is now well known to all that COVID 19, identified as a global pandemicby theWorld Health Organization in March 2020, is a disease characterized by a severe acute respiratory syndrome caused by a coronavirus called SARS-Cov2.
This virus has unfortunately been shown to be lethal, acting mainly on the lungs, but with pathological effects on other organs as well including, in particular, the renal, hematological, and nervous systems.
In fact, patients with COVID 19 may present with various neurological symptoms, and among these, one of the most common is headaches.
However, the worsening of headache during COVID-19 in many subjects who were already suffering from it is also significant.
The causes lie in the fact that many headache sufferers have been forced to forego medical checkups, and in particular taking medications dispensed at specialized centers, precisely because of the physical distancing, put in place to limit the spread of infection.
Other causes of the worsening of a pre-existing headache are related to the significant increase in stressors, including, in particular, forced changes in activities of daily living and giving up one’s activities, which have been a trigger for headaches through the onset of anxiety and depression.
In some neurological centers, the use of alternative options has been possible in order to minimize difficulties in physician-patient contact.
In this regard, one of the most interesting approaches is Telemedicine, which is a real-time interactive audio/video relationship between patient and physician, with also very high satisfaction rates.
However, some qualms have hindered a wider diffusion of this method: among them, the lack of technological capabilities on the part of the users, aspects related to patients’ privacy, or the impossibility of performing a valid neurological objective examination especially during the first visit.
